Adjuvant radiotherapy in the treatment of dedifferentiated liposarcoma of the spermatic cord: a rare entity

BMJ Case Rep. 2021 Jan 8;14(1):e238430. doi: 10.1136/bcr-2020-238430.

Abstract

Dedifferentiated liposarcoma (DDL) of the spermatic cord is a very rare entity in which management is remarkably controversial due to scarce literature. Although the actual standard of care is surgery via radical inguinal orchiectomy, adjuvant therapies like radiotherapy have demonstrated improved local control, particularly in cases with higher risk for local recurrence and worse prognosis. The role of adjuvant chemotherapy remains questionable in this subset of patients. On literature review, the most important prognostic factors for survival outcomes were surgical margin status, histological grade and the presence of metastases prior to the initial surgery. In this report, we discuss the case of a 59-year-old man with DDL of the spermatic cord that was treated with surgery followed by adjuvant radiotherapy. We also provide a comprehensive literature review about the management of this entity.

Keywords: urological cancer; urology.

Publication types

  • Case Reports

MeSH terms

  • Genital Neoplasms, Male / pathology
  • Genital Neoplasms, Male / radiotherapy*
  • Genital Neoplasms, Male / surgery*
  • Humans
  • Liposarcoma / pathology
  • Liposarcoma / radiotherapy*
  • Liposarcoma / surgery*
  • Male
  • Middle Aged
  • Radiotherapy, Adjuvant
  • Spermatic Cord*